(MS Journal) Commentary--patient voice: The label given to my MS disease course matters to me on: December 14, 2025, 09:03:33 pm #1 For some years Multiple Sclerosis Journal has been having regular short articles on two sides of a controversial topic, followed by a Commentary section summarizing the discussion. Now this journal has added a section called "Controversies: Patient Voice" where a view is offered on one side of an issue, written by a patient, and another patient view offers the other side, again followed by a Commentary section. What follows is the Commentary section only. From Multiple Sclerosis Journal (December 13, 2025)--"Patient Voice: The Label Given to My MS Disease Course Matters to Me--Commentary":https://journals.sagepub.com/doi/10.1177/13524585251396286?cookieSet=1 Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
